Rady Children’s Hospital in San Diego recently announced the single largest donation in its history.
Seeking and destroying lung cancer. Succeeding where Theranos failed. Treating resistant breast cancers.
MEDICINE: Surgery Co. Appears To Be Making Right Moves
A year ago, Chris Barry became the CEO of NuVasive, one of San Diego’s largest medical device companies. It wasn’t a caretaker role.
GENOMICS: Company Maneuvering to Get UK Approval of Acquisition
Illumina has proposed offering competitors free licenses to certain patents in hopes of getting U.K. regulatory approval to buy Pacific Biosciences.
BIOTECH: Founder to Remain as Chair
Thirteen years ago, Robin Toft landed in the emergency room with a colon cancer diagnosis.
Illumina has proposed offering competitors free licenses to certain patents in hopes of getting U.K. regulatory approval to buy Pacific Biosciences for $1.2 billion.
Seniors and patients with chronic conditions are more likely to cycle through emergency rooms. So why not bring regular care to them?
Predictive Analytics Also Used To Develop Surgical Plans
Carlsmed is a San Diego-based company that uses predictive analytics to develop personalized treatments for adult spinal deformities.
ACQUISITION: Tech Well-Suited for Women’s Health Applications
San Diego’s Daré Bioscience reached an agreement to acquire Microchips Biotech.
BIOTECH: It Orchestrates Hardware, Informs Users
Shuffling test tubes. Jotting down temperatures. Labeling samples. It’s Biosero’s job to get them all to work together.
Perlman Clinic has opened its ninth location – this one in the Del Mar Highlands Shopping Center.
Calporta Had Been Seeking a Buyer or Financial Backing
In 2017, Merck & Co. cut short a late-stage clinical trial of an Alzheimer’s drug because it wasn’t helping patients.
PHARMA: Drug Brings In $82M in Q3 Sales; Net Income Is $18M
In first quarter earnings ResMed posted $681.1 million in revenue, a 16% year-over-year increase.
Company Planned to Open Up Its Services to Middle-Class Market
Human Longevity Inc. has raised $30 million, a year after a letter from the company’s board signaled a cash crunch at the genomics outfit.
ZRG bought Toft Group, an executive search firm based in San Diego, it was announced Nov. 14.